Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 078479
Company: APOTEX
Company: APOTEX
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
BRIMONIDINE TARTRATE | BRIMONIDINE TARTRATE | 0.15% | SOLUTION/DROPS;OPHTHALMIC | Prescription | AT | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
01/31/2022 | ORIG-1 | Approval |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/078479Orig1s000ltr.pdf |
BRIMONIDINE TARTRATE
SOLUTION/DROPS;OPHTHALMIC; 0.15%
TE Code = AT
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
ALPHAGAN P | BRIMONIDINE TARTRATE | 0.15% | SOLUTION/DROPS;OPHTHALMIC | Prescription | Yes | AT | 021262 | ABBVIE |
BRIMONIDINE TARTRATE | BRIMONIDINE TARTRATE | 0.15% | SOLUTION/DROPS;OPHTHALMIC | Prescription | No | AT | 215225 | ALEMBIC |
BRIMONIDINE TARTRATE | BRIMONIDINE TARTRATE | 0.15% | SOLUTION/DROPS;OPHTHALMIC | Prescription | No | AT | 078479 | APOTEX |
BRIMONIDINE TARTRATE | BRIMONIDINE TARTRATE | 0.15% | SOLUTION/DROPS;OPHTHALMIC | Prescription | No | AT | 216772 | UPSHER SMITH LABS |
QOLIANA | BRIMONIDINE TARTRATE | 0.15% | SOLUTION/DROPS;OPHTHALMIC | Prescription | Yes | AT | 021764 | SANDOZ |